OpenAI has bought Orchestra Bio, a San Francisco startup that builds coordination software for clinical trials, and plans to fold it into Rosalind, its life sciences suite. We look at what AI agents could realistically take over in trial operations and which questions about rollout are still open.https://www.inferama.com/en/actualidad/openai-acquires-orchestra-bio-to-integrate-ai-agents-into-clinical-trial-management?utm_source=mastodon&utm_medium=social&utm_campaign=inferama#AI #ClinicalTrials
OpenAI has bought Orchestra Bio, a San Francisco startup that builds coordination software for clinical trials, and plan...
